Neovacs S.A. (0LW0)
Market Closed
7 Aug, 20:00
XMUN 
€
1. 14
+0.43
+60.5634%
€
- Market Cap
- P/E Ratio
- Div Yield
25 Volume
0 Eps
€ 0.71
Previous Close Want to track 0LW0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neovacs S.A. (0LW0) Statistics
Valuation metrics
Market Cap -
Enterprise value -
Trailing P/E (ttm) -0
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 269.59K
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1K
Average volume (90 days) 164.92K
Price summary
52-Week low 0.71
52-Week high 9,050
Beta -
50-Day moving average 0
200-Day moving average 0.07
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1,000
Last split Date 21 Jul 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Dec 2024
Profitability
Profit margin 0.12%
Operating margin -92.67%
Operational effectiveness
Return on assets -1.49%
Return on equity -1.82%
Income Statement
Revenue (ttm) 366.35K
Revenue per share (ttm) 1.36
Quarterly revenue growth (yoy) -
Gross profit (ttm) 42.42K
EBITDA -
Net income to common (ttm) -32.91M
Diluted EPS (ttm) -221.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 435.44K
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 0.63%
Book value per share (mrq) -
Cash Flow
Cash flow statement -12.52M
Levered free cash flow (LFCF) -32.91M
